Analogic (NASDAQ:ALOG) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Thursday.

Other research analysts have also recently issued research reports about the company. Jefferies Group began coverage on Analogic in a research note on Wednesday, August 9th. They issued a “hold” rating and a $75.00 price target on the stock. Zacks Investment Research lowered Analogic from a “buy” rating to a “hold” rating in a report on Tuesday, November 21st. One research analyst has rated the stock with a sell rating and four have assigned a hold rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $85.25.

Analogic (ALOG) opened at $80.65 on Thursday. The company has a market capitalization of $1,018.75, a PE ratio of 48.57, a price-to-earnings-growth ratio of 4.16 and a beta of 0.86. Analogic has a one year low of $66.00 and a one year high of $87.60.

Analogic (NASDAQ:ALOG) last released its quarterly earnings results on Wednesday, December 6th. The medical research company reported $0.75 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.43 by $0.32. Analogic had a positive return on equity of 4.27% and a negative net margin of 15.27%. The business had revenue of $106.90 million for the quarter, compared to analysts’ expectations of $100.55 million. During the same quarter in the previous year, the firm posted $0.43 earnings per share. The company’s revenue was down 11.7% compared to the same quarter last year. research analysts forecast that Analogic will post 2.8 earnings per share for the current fiscal year.

Large investors have recently bought and sold shares of the company. Flinton Capital Management LLC boosted its position in shares of Analogic by 100.0% during the second quarter. Flinton Capital Management LLC now owns 1,768 shares of the medical research company’s stock worth $129,000 after buying an additional 884 shares during the period. State Board of Administration of Florida Retirement System acquired a new position in shares of Analogic during the third quarter worth approximately $224,000. Piedmont Investment Advisors LLC acquired a new position in shares of Analogic during the third quarter worth approximately $227,000. Crossmark Global Holdings Inc. acquired a new position in shares of Analogic during the third quarter worth approximately $250,000. Finally, Oppenheimer & Co. Inc. acquired a new position in shares of Analogic during the second quarter worth approximately $263,000. 97.61% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Analogic (ALOG) Downgraded by BidaskClub to “Sell”” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright law. The legal version of this article can be viewed at

About Analogic

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Receive News & Ratings for Analogic Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Co. and related companies with's FREE daily email newsletter.